about
2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico.A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults.Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.Bluetongue in Belgium, 2006.Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments.Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8.DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge.Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.Bluetongue in northern Europe.Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1.Bluetongue in northern EuropeUncertainty of measurement for competitive and indirect ELISAsVaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology
P50
Q34575779-BEBB0910-8DF8-4333-8327-DF5F24EB14EDQ36026204-1F836BFB-87F6-4DA0-A9F8-D7105080CE63Q36523070-D5F1A17B-52E2-456E-8F43-EA4056F6AFB3Q37572768-22BF02B1-F192-46AA-9DA8-8A078E278AAFQ37694870-57C8B785-6CEC-4107-B3C0-5FD2DE0970C8Q40123163-FB34D39B-79F8-460A-9D7D-39712B9E321EQ40188672-A5BDC19C-EE4F-45E1-A7A3-A368FA4C2C3DQ40410109-4CBB3640-2E1F-48D8-BEAC-4D43B8989094Q42431819-15AEB507-2757-47E6-BAF0-188399AA3453Q45548025-0D556B7B-2049-4A18-ADF3-F4483061B749Q52672039-0B8782BA-3A38-423A-9D07-DA5DC58EB34FQ52979863-9FB840A5-EA57-4D02-B7AB-B6C70E2DB3E4Q80208419-33E71175-6EC5-4F83-8738-FCF10EE61699Q80755583-4D167B04-C0FC-46A0-A023-01637D6A02C4Q81679091-AF70EA14-C99B-4537-9225-02696E4814A3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jean-Francois Toussaint
@ast
Jean-Francois Toussaint
@en
Jean-Francois Toussaint
@es
Jean-Francois Toussaint
@nl
Jean-Francois Toussaint
@sl
type
label
Jean-Francois Toussaint
@ast
Jean-Francois Toussaint
@en
Jean-Francois Toussaint
@es
Jean-Francois Toussaint
@nl
Jean-Francois Toussaint
@sl
prefLabel
Jean-Francois Toussaint
@ast
Jean-Francois Toussaint
@en
Jean-Francois Toussaint
@es
Jean-Francois Toussaint
@nl
Jean-Francois Toussaint
@sl
P106
P1153
57194750037
P31
P496
0000-0003-1964-5039